drugset / Trial / NCT01055015
Double Blind Efficacy and Safety Study of Flexible-Dose vs Low-Dose Q8003 After Undergoing Primary Unilateral Total Knee Arthroplasty
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a Phase 3, two-arm, double-blind study of efficacy and safety of Q8003 in patients who have undergone primary unilateral total knee arthroplasty
Timeline
- Start
- 2010-02
- Primary completion
- 2010-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Morphine | Other / unclassified | 3 mg | — |
| Subject | Morphine | Other / unclassified | 6 mg | — |
| Subject | Morphine | Other / unclassified | 24 mg | — |
| Subject | Oxycodone | Other / unclassified | 2 mg | — |
| Subject | Oxycodone | Other / unclassified | 4 mg | — |
| Subject | Oxycodone | Other / unclassified | 16 mg | — |
Indications
No indication recorded.